MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$5,849,734
EPS
-$0.2
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
General and administrative
1,152,996
1,136,709
328,510*
1,754,856
Research and development
475,064
109,434
-210,527*
158,699
Total operating expenses
1,628,060
1,246,143
117,983
1,913,555
Loss from operations
-1,628,060
-1,246,143
-117,983*
-1,913,555
Net loss from change in fair value of derivative liability instrument
-3,341,568
697,561
2,487,591.5*
-
Gain from change in fair value of forward contract liability
-
-
-95,110.5*
-
Amortization of deferred offering cost
638,747
477,647
124,237*
-
Interest income
-
49,679
14,250*
5,111
Other income
-
5,578
163,740*
4,260
Interest income (expense), net
-241,359
-
-
-
Total other income (expense)
-4,221,674
275,171
2,636,455*
9,371
Net gain
-5,849,734
-970,972
2,518,472
-1,904,184
Basic EPS
-0.2
-0.03
0.092
-0.07
Diluted EPS
-0.2
-0.03
0.092
-0.07
Basic Average Shares
29,788,040
29,476,002
27,456,883
27,975,207
Diluted Average Shares
29,788,040
29,476,002
27,456,883
27,975,207
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net gain
-$5,849,734
Total other income
(expense)
-$4,221,674
Loss from operations
-$1,628,060
Net loss from change
in fair value of...
-$3,341,568
Amortization of deferred
offering cost
$638,747
Interest income
(expense), net
-$241,359
Total operating
expenses
$1,628,060
General and
administrative
$1,152,996
Research and development
$475,064
Buy us a coffee
Turn Therapeutics Inc. (TTRX)
Turn Therapeutics Inc. (TTRX)